Tag: Diabetes: Type II
New Diagnosis Code Added for Patients With Type 2 Diabetes in Remission
New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic range below 6.5% for at least three months
ACS: 2020 to 2024 Saw Jump in Use of GLP-1 Receptor Agonists Before Metabolic,...
Even higher use seen in patients without type 2 diabetes
Continuous Glucose Monitors Not Accurate in People Without Diabetes
Authors say in those without diabetes, continuous glucose monitors are not a substitute for HbA1c
Weight-Loss Treatment Tied to Lower Risk for Obesity-Related Cancers
Findings seen for both medication and surgical procedures in people with obesity and type 2 diabetes
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
Findings seen for long-term outcomes among adult patients with diabetes and obesity
Diabetes Tied to Doubled Risk for Sepsis
Smoking, high blood sugar, and other chronic conditions heighten risk
GLP-1 Receptor Agonists Improve Glycemic, Weight Outcomes in Children With T2D
Glycemic, weight, cardiometabolic outcomes improved for children and teens with obesity, prediabetes, or T2D
Cannabis Use Increases Diabetes Risk Nearly Fourfold
Authors say diabetes risk awareness needs to be integrated into substance use disorder treatment
Hormone Replacement Therapy Patches Safer Than Oral Delivery for Women With Diabetes
Oral therapy tied to increased cardiovascular risk but not for estrogen-sensitive cancers
Once-Weekly Semaglutide 7.2 mg Beats Placebo for Obesity
Second study shows 7.2 mg semaglutide leads to greater reductions in mean body weight for those with obesity, T2D
